期刊文献+

免碘过敏试验使用复方泛影葡胺行静脉肾盂造影检查分析 被引量:9

The application of compound meglumine diatrizoate in IVP without pretesting
下载PDF
导出
摘要 目的探讨免碘过敏试验使用76%复方泛影葡胺在静脉肾盂造影(IVP)的临床应用情况。方法2008年共1230名患者常规做静脉肾盂造影时免碘过敏试验静脉推注40ml76%复方泛影葡胺并全程观察患者的反应。结果在所有患者中仅有2例出于安全考虑改用非离子型对比剂,有52例出现轻中度过敏反应,发生各症状的人数与在2007年同时期行碘过敏试验阴性后IVP出现过敏反应症状比较无显著性差异。结论在做好预防和抢救措施的前提下进行免碘过敏试验静脉肾盂造影是安全可行的。 Objective To investigate the application of compound meglumine diatrizoate injection (CMDI) (76%) in IVP (intravenous pyelograpy) without pretesting. Methods To analyze the reactions of 1230 examiners who adopt the examination of IVP with an intravenous injection of 40 ml CMDI without pretesting. Results The mild anaphylaetic reaction appeared on 52 persons in all of the examiners and 2 persons use nonionic contrast medium compared with IVP with pretesting in 2007, the number of each anaphyiaetic reaction had no significant difference. Conclusion It is safe and practicable to take the examination of IVP without pretesting with full preparation for an emergency.
出处 《广州医药》 2009年第2期49-51,共3页 Guangzhou Medical Journal
关键词 泛影葡胺 过敏试验 静脉肾盂造影 Compound meglumine diatrizoate Allergy test Intravenous pydograpy (IVP)
  • 相关文献

参考文献5

  • 1无.对比剂使用指南(第1版)[J].中华放射学杂志,2008,42(3):320-325. 被引量:72
  • 2Itoh S, Ikeda M, Achiwa M, et al. Multiphase Contrast enhanced CT of the Live with a Multislice CT Scanner [J] . Eur Rediol, 2003, 13: 1085.
  • 3Fenchel S, Fleeter TR, Aschoff AJ, et al. Effect of iodine conce tration of contrast media on contrast enhancement in muhislic CT of the Panctreas [J]. Brit J Radiol, 2004, 77 (10): 8212830.
  • 4李兆祥.非离子型对比剂不良反应的表现、发生机理及预防处理.中国实用医药,2007,2(27):105-107.
  • 5黎锐芳,王琼芳,邓晓莲,廖瑞珍.造影剂不良反应的护理与预防[J].当代护士(中旬刊),2008,15(2):50-51. 被引量:6

二级参考文献38

  • 1吴雪琴,岑玉坚,崔冰,梁瑞莲,欧洁红,王浩.应用高压注射器进行CT血管造影时的护理[J].护士进修杂志,2004,19(12):1114-1115. 被引量:53
  • 2李彪,齐海梅,裕东洁,姚稚明,汤天清,赵洪山,褚德发,吴华.Cockcroft-Gault公式和简化MDRD公式估算老年人肾功能准确性的比较研究[J].中华老年医学杂志,2007,26(2):97-100. 被引量:19
  • 3Yamaguchi K, Katayama H, Takashima T, et al. Prediction of severe adverse reactions to ionic and nonionic contrast media in Japan: evaluation of pretesting. A report from the Japanese Committee on the Safety of Contrast Media. Radiology, 1991, 178:363-367.
  • 4Widmark JM. Imaging-related medications: a class overview. Proc (Bayl Univ Med Cent), 2007, 20:408-417.
  • 5Thomsen HS, Morcos SK. Contrast-medium-induced nephropathy: is there a new consensus? A review of published guidelines. Eur Badiol, 2006,16:1835-1840.
  • 6Al Ghonaim M, Pannu N. Prevention and treatment of contrastinduced nephropathy. Tech Vase lnterv Radiol, 2006, 9:42-49.
  • 7McCullough PA, Adam A, Becker CR, et al. Epidemiology and prognostic implications of contrast-induced nephropathy. Am J Cardiol, 2006, 98 :SK-13K.
  • 8McCuUough P. Outcomes of contrast-induced nephropathy: experience in patientsundergoing cardiovascular intervention. Catheter Cardiovasc lnterv, 2006, 67:335-343.
  • 9Pannu N, Wiebe N, Tonelli M. Prophylaxis strategies for contrastinduced nephropathy..lAMA, 2006, 295:2765-2779.
  • 10Tepel M, Aspelin P, Lameire N. Contrast-induced nephropathy: a clinical and evidence-based approach. Circulation, 2006, 113: 1799 -1806.

共引文献89

同被引文献52

引证文献9

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部